Biocon to hive off biosimilars business
have said that they would not back the project. Adani and Downer have agreed to cancel all letters of award for mine services and related infrastructure. Biotechnology company Biocon has said that it has received shareholders' approval to the resolution for transfer of its biosimilars business by way of a slump sale to group entity Biocon Biologics India. "The resolution for transfer of Biosimilars business of the company by way of a slump sale as a going concern to Biocon Biologics India has been passed by the members of the company with requisite majority," Biocon has said.